Review



brd4 expression  (Genecopoeia)


Bioz Verified Symbol Genecopoeia is a verified supplier
Bioz Manufacturer Symbol Genecopoeia manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    Genecopoeia brd4 expression
    FIGURE 1 MiR-152-5p was downregulated and <t>bromodomain</t> <t>containing</t> <t>4</t> <t>(BRD4)</t> was upregulated in cervical carcinoma tissue and adjacent normal tissues. (A) The expression of miR-152-5p was detected by quantitative real-time PCR (qRT-PCR) in cervical carcinoma tissue and adjacent normal tissues. (B) The expression of <t>BRD4</t> was detected by qRT-PCR. (C) The correlation was analyzed by Pearson's analysis. ***p < 0.001
    Brd4 Expression, supplied by Genecopoeia, used in various techniques. Bioz Stars score: 94/100, based on 2 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/orf+expression+clone+for+brd4/ORF+expression+clone+for+BRD4/pm33611824-55-4-11
    Average 94 stars, based on 2 article reviews
    brd4 expression - by Bioz Stars, 2026-10
    94/100 stars

    Images

    1) Product Images from "Apigenin suppresses proliferation, invasion, and epithelial-mesenchymal transition of cervical carcinoma cells by regulation of miR-152/BRD4 axis."

    Article Title: Apigenin suppresses proliferation, invasion, and epithelial-mesenchymal transition of cervical carcinoma cells by regulation of miR-152/BRD4 axis.

    Journal: The Kaohsiung journal of medical sciences

    doi: 10.1002/kjm2.12370

    FIGURE 1 MiR-152-5p was downregulated and bromodomain containing 4 (BRD4) was upregulated in cervical carcinoma tissue and adjacent normal tissues. (A) The expression of miR-152-5p was detected by quantitative real-time PCR (qRT-PCR) in cervical carcinoma tissue and adjacent normal tissues. (B) The expression of BRD4 was detected by qRT-PCR. (C) The correlation was analyzed by Pearson's analysis. ***p < 0.001
    Figure Legend Snippet: FIGURE 1 MiR-152-5p was downregulated and bromodomain containing 4 (BRD4) was upregulated in cervical carcinoma tissue and adjacent normal tissues. (A) The expression of miR-152-5p was detected by quantitative real-time PCR (qRT-PCR) in cervical carcinoma tissue and adjacent normal tissues. (B) The expression of BRD4 was detected by qRT-PCR. (C) The correlation was analyzed by Pearson's analysis. ***p < 0.001

    Techniques Used: Expressing, Real-time Polymerase Chain Reaction, Quantitative RT-PCR

    FIGURE 2 Apigenin inhibited the proliferation and invasion of cervical carcinoma cells by regulating miR-152-5p expression. (A) Quantitative real-time PCR (qRT-PCR) was conducted to determine the expression of miR-152-5p and bromodomain containing 4 (BRD4) in cell lines of HOSEpiC, C33A, Hela, SiHa, and CaSki. (B) qRT-PCR was used to detect the transfection efficiency of miR-152-5p in Hela and CaSki cells transfected with miR- 152-5p inhibitor and the NC inhibitor. (C) MTT was conducted to evaluate the proliferation in Hela and CaSki cells treated with apigenin, cells treated with apigenin and transfected with miR-152-5p inhibitor, cells treated with apigenin and transfected with NC, and negative control, respectively. (D) Transwell invasion assay was applied to determine the cell invasion. ***p < 0.001
    Figure Legend Snippet: FIGURE 2 Apigenin inhibited the proliferation and invasion of cervical carcinoma cells by regulating miR-152-5p expression. (A) Quantitative real-time PCR (qRT-PCR) was conducted to determine the expression of miR-152-5p and bromodomain containing 4 (BRD4) in cell lines of HOSEpiC, C33A, Hela, SiHa, and CaSki. (B) qRT-PCR was used to detect the transfection efficiency of miR-152-5p in Hela and CaSki cells transfected with miR- 152-5p inhibitor and the NC inhibitor. (C) MTT was conducted to evaluate the proliferation in Hela and CaSki cells treated with apigenin, cells treated with apigenin and transfected with miR-152-5p inhibitor, cells treated with apigenin and transfected with NC, and negative control, respectively. (D) Transwell invasion assay was applied to determine the cell invasion. ***p < 0.001

    Techniques Used: Expressing, Real-time Polymerase Chain Reaction, Quantitative RT-PCR, Transfection, Negative Control, Transwell Invasion Assay

    FIGURE 3 Apigenin inhibited epithelial–mesenchymal transition (EMT) of cervical carcinoma cells by regulating miR- 152-5p expression. (A) Quantitative real- time PCR (qRT-PCR) was used to calculate the expression of miR-152-5p and bromodomain containing 4 (BRD4). (B) Western blotting was conducted to detect the protein level of BRD4, E- cadherin, N-cadherin, and MMP9. ***p < 0.001
    Figure Legend Snippet: FIGURE 3 Apigenin inhibited epithelial–mesenchymal transition (EMT) of cervical carcinoma cells by regulating miR- 152-5p expression. (A) Quantitative real- time PCR (qRT-PCR) was used to calculate the expression of miR-152-5p and bromodomain containing 4 (BRD4). (B) Western blotting was conducted to detect the protein level of BRD4, E- cadherin, N-cadherin, and MMP9. ***p < 0.001

    Techniques Used: Expressing, Real-time Polymerase Chain Reaction, Quantitative RT-PCR, Western Blot

    FIGURE 4 Apigenin suppressed the proliferation and invasion of Hela and CaSki cells through regulating bromodomain containing 4 (BRD4) expression. (A) Quantitative real-time PCR (qRT-PCR) was used to detect the transfection efficiency of BRD4 in Hela and CaSki cells transfected with pcDNA3.1-BRD4 and the negative control (NC) control. (B) MTT was conducted to evaluate the proliferation of Hela and CaSki cells treated with apigenin, cells treated with apigenin and transfected with pcDNA3.1-BRD4, cells treated with apigenin and transfected with NC, and negative control, respectively. (C) Transwell was applied to determine the cell invasion. ***p < 0.001
    Figure Legend Snippet: FIGURE 4 Apigenin suppressed the proliferation and invasion of Hela and CaSki cells through regulating bromodomain containing 4 (BRD4) expression. (A) Quantitative real-time PCR (qRT-PCR) was used to detect the transfection efficiency of BRD4 in Hela and CaSki cells transfected with pcDNA3.1-BRD4 and the negative control (NC) control. (B) MTT was conducted to evaluate the proliferation of Hela and CaSki cells treated with apigenin, cells treated with apigenin and transfected with pcDNA3.1-BRD4, cells treated with apigenin and transfected with NC, and negative control, respectively. (C) Transwell was applied to determine the cell invasion. ***p < 0.001

    Techniques Used: Expressing, Real-time Polymerase Chain Reaction, Quantitative RT-PCR, Transfection, Negative Control, Control

    FIGURE 5 Apigenin inhibited epithelial–mesenchymal transition (EMT) of Hela and CaSki cells through regulating bromodomain containing 4 (BRD4) expression. (A) Quantitative real-time PCR (qRT-PCR) was used to calculate the expression of BRD4. (B) Western blotting was conducted to detect the protein level of BRD4, E-cadherin, N- cadherin, and MMP9. ***p < 0.001
    Figure Legend Snippet: FIGURE 5 Apigenin inhibited epithelial–mesenchymal transition (EMT) of Hela and CaSki cells through regulating bromodomain containing 4 (BRD4) expression. (A) Quantitative real-time PCR (qRT-PCR) was used to calculate the expression of BRD4. (B) Western blotting was conducted to detect the protein level of BRD4, E-cadherin, N- cadherin, and MMP9. ***p < 0.001

    Techniques Used: Expressing, Real-time Polymerase Chain Reaction, Quantitative RT-PCR, Western Blot

    FIGURE 6 miR-152-5p could directly bind to bromodomain containing 4 (BRD4) in Hela and CaSki cells. (a) The binding site of miR-152-5p with BRD4 was predicted according to TargetScan (http://www. targetscan.org/).(B) Quantitative real-time PCR (qRT-PCR) was used to detect the transfection efficiency of miR-152-5p in Hela and CaSki cells transfected with miR-152-5p mimics and the negative control (NC) mimics. (C) Targeting relationship between miR-152-5p and BRD4 was identified by luciferase reporter assay. ***p < 0.001
    Figure Legend Snippet: FIGURE 6 miR-152-5p could directly bind to bromodomain containing 4 (BRD4) in Hela and CaSki cells. (a) The binding site of miR-152-5p with BRD4 was predicted according to TargetScan (http://www. targetscan.org/).(B) Quantitative real-time PCR (qRT-PCR) was used to detect the transfection efficiency of miR-152-5p in Hela and CaSki cells transfected with miR-152-5p mimics and the negative control (NC) mimics. (C) Targeting relationship between miR-152-5p and BRD4 was identified by luciferase reporter assay. ***p < 0.001

    Techniques Used: Binding Assay, Real-time Polymerase Chain Reaction, Quantitative RT-PCR, Transfection, Negative Control, Luciferase, Reporter Assay

    FIGURE 7 Apigenin suppressed proliferation and invasion by regulating miR-152-5p/bromodomain containing 4 (BRD4) axis in Hela and CaSki cells. (A) Quantitative real-time PCR (qRT-PCR) was used to detect the transfection efficiency of BRD4 in Hela and CaSki cells transfected with si-BRD4 and the negative control (NC) control. (B) MTT was conducted to determine the proliferation of cells treated with apigenin and transfected with miR-152-5p inhibitor, cells treated with apigenin and co-transfected with miR-152-5p inhibitor and si-NC, cells treated with apigenin and co-transfected with miR-152-5p inhibitor and si-BRD4, and the control. (C) Transwell invasion assay was performed to evaluate the cell invasion. ***p < 0.001
    Figure Legend Snippet: FIGURE 7 Apigenin suppressed proliferation and invasion by regulating miR-152-5p/bromodomain containing 4 (BRD4) axis in Hela and CaSki cells. (A) Quantitative real-time PCR (qRT-PCR) was used to detect the transfection efficiency of BRD4 in Hela and CaSki cells transfected with si-BRD4 and the negative control (NC) control. (B) MTT was conducted to determine the proliferation of cells treated with apigenin and transfected with miR-152-5p inhibitor, cells treated with apigenin and co-transfected with miR-152-5p inhibitor and si-NC, cells treated with apigenin and co-transfected with miR-152-5p inhibitor and si-BRD4, and the control. (C) Transwell invasion assay was performed to evaluate the cell invasion. ***p < 0.001

    Techniques Used: Real-time Polymerase Chain Reaction, Quantitative RT-PCR, Transfection, Negative Control, Control, Transwell Invasion Assay

    FIGURE 8 Apigenin suppressed epithelial–mesenchymal transition (EMT) by regulating miR-152-5p/bromodomain containing 4 (BRD4) axis in Hela and CaSki cells. (A) Quantitative real-time PCR (qRT-PCR) was used to calculate the expression of BRD4. (B) Western blotting was conducted to detect the protein level of BRD4, E-cadherin, N-cadherin, and MMP9. ***p < 0.001
    Figure Legend Snippet: FIGURE 8 Apigenin suppressed epithelial–mesenchymal transition (EMT) by regulating miR-152-5p/bromodomain containing 4 (BRD4) axis in Hela and CaSki cells. (A) Quantitative real-time PCR (qRT-PCR) was used to calculate the expression of BRD4. (B) Western blotting was conducted to detect the protein level of BRD4, E-cadherin, N-cadherin, and MMP9. ***p < 0.001

    Techniques Used: Real-time Polymerase Chain Reaction, Quantitative RT-PCR, Expressing, Western Blot

    Related Articles

    Control:

    Article Title: BRD4 regulates key transcription factors that drive epithelial-mesenchymal transition in castration-resistant prostate cancer
    Article Snippet: pho-Smad3 (Abcam). Additional information is available in a Supplementary File . Lentivirus-mediated eGFP-BRD4 expressing plasmid (EX-E0102-Lv122) and control vector (EX-NEG-Lv242) were purchased from GeneCopoeia. ON-Targetplus Human BET and Non-Targeting (scramble) SMARTpool siRNAs were purchased from Dharmacon. Additional information is available in a Supplementary File . Cell pellets were lysed

    Expressing:

    Article Title: BRD4 regulates key transcription factors that drive epithelial-mesenchymal transition in castration-resistant prostate cancer
    Article Snippet: pho-Smad3 (Abcam). Additional information is available in a Supplementary File . Lentivirus-mediated eGFP-BRD4 expressing plasmid (EX-E0102-Lv122) and control vector (EX-NEG-Lv242) were purchased from GeneCopoeia. ON-Targetplus Human BET and Non-Targeting (scramble) SMARTpool siRNAs were purchased from Dharmacon. Additional information is available in a Supplementary File . Cell pellets were lysed

    Plasmid Preparation:

    Article Title: BRD4 regulates key transcription factors that drive epithelial-mesenchymal transition in castration-resistant prostate cancer
    Article Snippet: pho-Smad3 (Abcam). Additional information is available in a Supplementary File . Lentivirus-mediated eGFP-BRD4 expressing plasmid (EX-E0102-Lv122) and control vector (EX-NEG-Lv242) were purchased from GeneCopoeia. ON-Targetplus Human BET and Non-Targeting (scramble) SMARTpool siRNAs were purchased from Dharmacon. Additional information is available in a Supplementary File . Cell pellets were lysed



    Similar Products

    94
    Genecopoeia brd4 expression
    FIGURE 1 MiR-152-5p was downregulated and <t>bromodomain</t> <t>containing</t> <t>4</t> <t>(BRD4)</t> was upregulated in cervical carcinoma tissue and adjacent normal tissues. (A) The expression of miR-152-5p was detected by quantitative real-time PCR (qRT-PCR) in cervical carcinoma tissue and adjacent normal tissues. (B) The expression of <t>BRD4</t> was detected by qRT-PCR. (C) The correlation was analyzed by Pearson's analysis. ***p < 0.001
    Brd4 Expression, supplied by Genecopoeia, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/orf+expression+clone+for+brd4/ORF+expression+clone+for+BRD4/pm33611824-55-4-11
    Average 94 stars, based on 1 article reviews
    brd4 expression - by Bioz Stars, 2026-10
    94/100 stars
      Buy from Supplier

    Image Search Results


    FIGURE 1 MiR-152-5p was downregulated and bromodomain containing 4 (BRD4) was upregulated in cervical carcinoma tissue and adjacent normal tissues. (A) The expression of miR-152-5p was detected by quantitative real-time PCR (qRT-PCR) in cervical carcinoma tissue and adjacent normal tissues. (B) The expression of BRD4 was detected by qRT-PCR. (C) The correlation was analyzed by Pearson's analysis. ***p < 0.001

    Journal: The Kaohsiung journal of medical sciences

    Article Title: Apigenin suppresses proliferation, invasion, and epithelial-mesenchymal transition of cervical carcinoma cells by regulation of miR-152/BRD4 axis.

    doi: 10.1002/kjm2.12370

    Figure Lengend Snippet: FIGURE 1 MiR-152-5p was downregulated and bromodomain containing 4 (BRD4) was upregulated in cervical carcinoma tissue and adjacent normal tissues. (A) The expression of miR-152-5p was detected by quantitative real-time PCR (qRT-PCR) in cervical carcinoma tissue and adjacent normal tissues. (B) The expression of BRD4 was detected by qRT-PCR. (C) The correlation was analyzed by Pearson's analysis. ***p < 0.001

    Article Snippet: For the detection of BRD4 expression, PrimeScript RT reagent Kit (QP015, GeneCopoeia, USA) was used for reverse transcription, and SYBR Premix Ex Taq (TaKaRa Biotechnology, Dalian, China) on SYBRTM Green PCR Master Mix (Applied Biosystems, Foster City, CA) were applied for the evaluation.

    Techniques: Expressing, Real-time Polymerase Chain Reaction, Quantitative RT-PCR

    FIGURE 2 Apigenin inhibited the proliferation and invasion of cervical carcinoma cells by regulating miR-152-5p expression. (A) Quantitative real-time PCR (qRT-PCR) was conducted to determine the expression of miR-152-5p and bromodomain containing 4 (BRD4) in cell lines of HOSEpiC, C33A, Hela, SiHa, and CaSki. (B) qRT-PCR was used to detect the transfection efficiency of miR-152-5p in Hela and CaSki cells transfected with miR- 152-5p inhibitor and the NC inhibitor. (C) MTT was conducted to evaluate the proliferation in Hela and CaSki cells treated with apigenin, cells treated with apigenin and transfected with miR-152-5p inhibitor, cells treated with apigenin and transfected with NC, and negative control, respectively. (D) Transwell invasion assay was applied to determine the cell invasion. ***p < 0.001

    Journal: The Kaohsiung journal of medical sciences

    Article Title: Apigenin suppresses proliferation, invasion, and epithelial-mesenchymal transition of cervical carcinoma cells by regulation of miR-152/BRD4 axis.

    doi: 10.1002/kjm2.12370

    Figure Lengend Snippet: FIGURE 2 Apigenin inhibited the proliferation and invasion of cervical carcinoma cells by regulating miR-152-5p expression. (A) Quantitative real-time PCR (qRT-PCR) was conducted to determine the expression of miR-152-5p and bromodomain containing 4 (BRD4) in cell lines of HOSEpiC, C33A, Hela, SiHa, and CaSki. (B) qRT-PCR was used to detect the transfection efficiency of miR-152-5p in Hela and CaSki cells transfected with miR- 152-5p inhibitor and the NC inhibitor. (C) MTT was conducted to evaluate the proliferation in Hela and CaSki cells treated with apigenin, cells treated with apigenin and transfected with miR-152-5p inhibitor, cells treated with apigenin and transfected with NC, and negative control, respectively. (D) Transwell invasion assay was applied to determine the cell invasion. ***p < 0.001

    Article Snippet: For the detection of BRD4 expression, PrimeScript RT reagent Kit (QP015, GeneCopoeia, USA) was used for reverse transcription, and SYBR Premix Ex Taq (TaKaRa Biotechnology, Dalian, China) on SYBRTM Green PCR Master Mix (Applied Biosystems, Foster City, CA) were applied for the evaluation.

    Techniques: Expressing, Real-time Polymerase Chain Reaction, Quantitative RT-PCR, Transfection, Negative Control, Transwell Invasion Assay

    FIGURE 3 Apigenin inhibited epithelial–mesenchymal transition (EMT) of cervical carcinoma cells by regulating miR- 152-5p expression. (A) Quantitative real- time PCR (qRT-PCR) was used to calculate the expression of miR-152-5p and bromodomain containing 4 (BRD4). (B) Western blotting was conducted to detect the protein level of BRD4, E- cadherin, N-cadherin, and MMP9. ***p < 0.001

    Journal: The Kaohsiung journal of medical sciences

    Article Title: Apigenin suppresses proliferation, invasion, and epithelial-mesenchymal transition of cervical carcinoma cells by regulation of miR-152/BRD4 axis.

    doi: 10.1002/kjm2.12370

    Figure Lengend Snippet: FIGURE 3 Apigenin inhibited epithelial–mesenchymal transition (EMT) of cervical carcinoma cells by regulating miR- 152-5p expression. (A) Quantitative real- time PCR (qRT-PCR) was used to calculate the expression of miR-152-5p and bromodomain containing 4 (BRD4). (B) Western blotting was conducted to detect the protein level of BRD4, E- cadherin, N-cadherin, and MMP9. ***p < 0.001

    Article Snippet: For the detection of BRD4 expression, PrimeScript RT reagent Kit (QP015, GeneCopoeia, USA) was used for reverse transcription, and SYBR Premix Ex Taq (TaKaRa Biotechnology, Dalian, China) on SYBRTM Green PCR Master Mix (Applied Biosystems, Foster City, CA) were applied for the evaluation.

    Techniques: Expressing, Real-time Polymerase Chain Reaction, Quantitative RT-PCR, Western Blot

    FIGURE 4 Apigenin suppressed the proliferation and invasion of Hela and CaSki cells through regulating bromodomain containing 4 (BRD4) expression. (A) Quantitative real-time PCR (qRT-PCR) was used to detect the transfection efficiency of BRD4 in Hela and CaSki cells transfected with pcDNA3.1-BRD4 and the negative control (NC) control. (B) MTT was conducted to evaluate the proliferation of Hela and CaSki cells treated with apigenin, cells treated with apigenin and transfected with pcDNA3.1-BRD4, cells treated with apigenin and transfected with NC, and negative control, respectively. (C) Transwell was applied to determine the cell invasion. ***p < 0.001

    Journal: The Kaohsiung journal of medical sciences

    Article Title: Apigenin suppresses proliferation, invasion, and epithelial-mesenchymal transition of cervical carcinoma cells by regulation of miR-152/BRD4 axis.

    doi: 10.1002/kjm2.12370

    Figure Lengend Snippet: FIGURE 4 Apigenin suppressed the proliferation and invasion of Hela and CaSki cells through regulating bromodomain containing 4 (BRD4) expression. (A) Quantitative real-time PCR (qRT-PCR) was used to detect the transfection efficiency of BRD4 in Hela and CaSki cells transfected with pcDNA3.1-BRD4 and the negative control (NC) control. (B) MTT was conducted to evaluate the proliferation of Hela and CaSki cells treated with apigenin, cells treated with apigenin and transfected with pcDNA3.1-BRD4, cells treated with apigenin and transfected with NC, and negative control, respectively. (C) Transwell was applied to determine the cell invasion. ***p < 0.001

    Article Snippet: For the detection of BRD4 expression, PrimeScript RT reagent Kit (QP015, GeneCopoeia, USA) was used for reverse transcription, and SYBR Premix Ex Taq (TaKaRa Biotechnology, Dalian, China) on SYBRTM Green PCR Master Mix (Applied Biosystems, Foster City, CA) were applied for the evaluation.

    Techniques: Expressing, Real-time Polymerase Chain Reaction, Quantitative RT-PCR, Transfection, Negative Control, Control

    FIGURE 5 Apigenin inhibited epithelial–mesenchymal transition (EMT) of Hela and CaSki cells through regulating bromodomain containing 4 (BRD4) expression. (A) Quantitative real-time PCR (qRT-PCR) was used to calculate the expression of BRD4. (B) Western blotting was conducted to detect the protein level of BRD4, E-cadherin, N- cadherin, and MMP9. ***p < 0.001

    Journal: The Kaohsiung journal of medical sciences

    Article Title: Apigenin suppresses proliferation, invasion, and epithelial-mesenchymal transition of cervical carcinoma cells by regulation of miR-152/BRD4 axis.

    doi: 10.1002/kjm2.12370

    Figure Lengend Snippet: FIGURE 5 Apigenin inhibited epithelial–mesenchymal transition (EMT) of Hela and CaSki cells through regulating bromodomain containing 4 (BRD4) expression. (A) Quantitative real-time PCR (qRT-PCR) was used to calculate the expression of BRD4. (B) Western blotting was conducted to detect the protein level of BRD4, E-cadherin, N- cadherin, and MMP9. ***p < 0.001

    Article Snippet: For the detection of BRD4 expression, PrimeScript RT reagent Kit (QP015, GeneCopoeia, USA) was used for reverse transcription, and SYBR Premix Ex Taq (TaKaRa Biotechnology, Dalian, China) on SYBRTM Green PCR Master Mix (Applied Biosystems, Foster City, CA) were applied for the evaluation.

    Techniques: Expressing, Real-time Polymerase Chain Reaction, Quantitative RT-PCR, Western Blot

    FIGURE 6 miR-152-5p could directly bind to bromodomain containing 4 (BRD4) in Hela and CaSki cells. (a) The binding site of miR-152-5p with BRD4 was predicted according to TargetScan (http://www. targetscan.org/).(B) Quantitative real-time PCR (qRT-PCR) was used to detect the transfection efficiency of miR-152-5p in Hela and CaSki cells transfected with miR-152-5p mimics and the negative control (NC) mimics. (C) Targeting relationship between miR-152-5p and BRD4 was identified by luciferase reporter assay. ***p < 0.001

    Journal: The Kaohsiung journal of medical sciences

    Article Title: Apigenin suppresses proliferation, invasion, and epithelial-mesenchymal transition of cervical carcinoma cells by regulation of miR-152/BRD4 axis.

    doi: 10.1002/kjm2.12370

    Figure Lengend Snippet: FIGURE 6 miR-152-5p could directly bind to bromodomain containing 4 (BRD4) in Hela and CaSki cells. (a) The binding site of miR-152-5p with BRD4 was predicted according to TargetScan (http://www. targetscan.org/).(B) Quantitative real-time PCR (qRT-PCR) was used to detect the transfection efficiency of miR-152-5p in Hela and CaSki cells transfected with miR-152-5p mimics and the negative control (NC) mimics. (C) Targeting relationship between miR-152-5p and BRD4 was identified by luciferase reporter assay. ***p < 0.001

    Article Snippet: For the detection of BRD4 expression, PrimeScript RT reagent Kit (QP015, GeneCopoeia, USA) was used for reverse transcription, and SYBR Premix Ex Taq (TaKaRa Biotechnology, Dalian, China) on SYBRTM Green PCR Master Mix (Applied Biosystems, Foster City, CA) were applied for the evaluation.

    Techniques: Binding Assay, Real-time Polymerase Chain Reaction, Quantitative RT-PCR, Transfection, Negative Control, Luciferase, Reporter Assay

    FIGURE 7 Apigenin suppressed proliferation and invasion by regulating miR-152-5p/bromodomain containing 4 (BRD4) axis in Hela and CaSki cells. (A) Quantitative real-time PCR (qRT-PCR) was used to detect the transfection efficiency of BRD4 in Hela and CaSki cells transfected with si-BRD4 and the negative control (NC) control. (B) MTT was conducted to determine the proliferation of cells treated with apigenin and transfected with miR-152-5p inhibitor, cells treated with apigenin and co-transfected with miR-152-5p inhibitor and si-NC, cells treated with apigenin and co-transfected with miR-152-5p inhibitor and si-BRD4, and the control. (C) Transwell invasion assay was performed to evaluate the cell invasion. ***p < 0.001

    Journal: The Kaohsiung journal of medical sciences

    Article Title: Apigenin suppresses proliferation, invasion, and epithelial-mesenchymal transition of cervical carcinoma cells by regulation of miR-152/BRD4 axis.

    doi: 10.1002/kjm2.12370

    Figure Lengend Snippet: FIGURE 7 Apigenin suppressed proliferation and invasion by regulating miR-152-5p/bromodomain containing 4 (BRD4) axis in Hela and CaSki cells. (A) Quantitative real-time PCR (qRT-PCR) was used to detect the transfection efficiency of BRD4 in Hela and CaSki cells transfected with si-BRD4 and the negative control (NC) control. (B) MTT was conducted to determine the proliferation of cells treated with apigenin and transfected with miR-152-5p inhibitor, cells treated with apigenin and co-transfected with miR-152-5p inhibitor and si-NC, cells treated with apigenin and co-transfected with miR-152-5p inhibitor and si-BRD4, and the control. (C) Transwell invasion assay was performed to evaluate the cell invasion. ***p < 0.001

    Article Snippet: For the detection of BRD4 expression, PrimeScript RT reagent Kit (QP015, GeneCopoeia, USA) was used for reverse transcription, and SYBR Premix Ex Taq (TaKaRa Biotechnology, Dalian, China) on SYBRTM Green PCR Master Mix (Applied Biosystems, Foster City, CA) were applied for the evaluation.

    Techniques: Real-time Polymerase Chain Reaction, Quantitative RT-PCR, Transfection, Negative Control, Control, Transwell Invasion Assay

    FIGURE 8 Apigenin suppressed epithelial–mesenchymal transition (EMT) by regulating miR-152-5p/bromodomain containing 4 (BRD4) axis in Hela and CaSki cells. (A) Quantitative real-time PCR (qRT-PCR) was used to calculate the expression of BRD4. (B) Western blotting was conducted to detect the protein level of BRD4, E-cadherin, N-cadherin, and MMP9. ***p < 0.001

    Journal: The Kaohsiung journal of medical sciences

    Article Title: Apigenin suppresses proliferation, invasion, and epithelial-mesenchymal transition of cervical carcinoma cells by regulation of miR-152/BRD4 axis.

    doi: 10.1002/kjm2.12370

    Figure Lengend Snippet: FIGURE 8 Apigenin suppressed epithelial–mesenchymal transition (EMT) by regulating miR-152-5p/bromodomain containing 4 (BRD4) axis in Hela and CaSki cells. (A) Quantitative real-time PCR (qRT-PCR) was used to calculate the expression of BRD4. (B) Western blotting was conducted to detect the protein level of BRD4, E-cadherin, N-cadherin, and MMP9. ***p < 0.001

    Article Snippet: For the detection of BRD4 expression, PrimeScript RT reagent Kit (QP015, GeneCopoeia, USA) was used for reverse transcription, and SYBR Premix Ex Taq (TaKaRa Biotechnology, Dalian, China) on SYBRTM Green PCR Master Mix (Applied Biosystems, Foster City, CA) were applied for the evaluation.

    Techniques: Real-time Polymerase Chain Reaction, Quantitative RT-PCR, Expressing, Western Blot